Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Drug Resistance, Multiple”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT07058233
What this trial is testing

Oral Nutritional Supplementation and Weight Changes During Therapy in Malnourished Patients With Resistant Tuberculosis: A Clinical Trial

Who this might be right for
Tuberculosis Multi Drug Resistant ActiveRifampin-Resistant Pulmonary TuberculosisPre-xdr tb
RSUP Persahabatan 70
Not applicableStudy completedNCT03352804
What this trial is testing

Are the Patients Having Pets at Greater Risk of Carrying Multidrug Resistance Bacteriae?

Who this might be right for
Multidrug Resistance
CHU de Reims 900
Not applicableStudy completedNCT03127358
What this trial is testing

Smartphone Based aDOT Treatment With Fixed-Dose Elbasvir and Grazoprevir in PWIDs

Who this might be right for
Hepatitis CMedication Adherence
Albert Einstein College of Medicine 11
Not applicableStudy completedNCT06729476
What this trial is testing

The Effect of Uroshield on Sputum-specimen Bacterial Growth

Who this might be right for
Mechanically Ventilated Patients
Shaare Zedek Medical Center 48
Early research (Phase 1)Study completedNCT00256191
What this trial is testing

Study of TPI 287 Administered Every 21 Days in Patients With Advanced Malignancies

Who this might be right for
NeoplasmsHodgkin's DiseaseNon-Hodgkin's Lymphoma
Cortice Biosciences, Inc. 45
Not applicableStudy completedNCT05378217
What this trial is testing

AMR-DetecTool for the Diagnostic of MDR Bacterial Infections

Who this might be right for
Bacterial Sensitivity TestsAntimicrobial Drug Resistance
Assistance Publique - Hôpitaux de Paris 167
Not applicableLooking for participantsNCT05947656
What this trial is testing

Evaluation of the NaviFUS System in Drug Resistant Epilepsy

Who this might be right for
Epilepsy, Temporal LobeDrug Resistant Epilepsy
Genovate-NaviFUS (Australia) Pty Ltd. 18
Testing effectiveness (Phase 2)Looking for participantsNCT05791396
What this trial is testing

FMT to Eradicate Intestinal Colonization by Carbapenem-resistant Enterobacteriaceae

Who this might be right for
Enterobacteriaceae InfectionsMulti-antibiotic Resistance
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 36
Testing effectiveness (Phase 2)Ended earlyNCT05288062
What this trial is testing

Immunomodulatory Drugs (Lenalidomide With or Without Pomalidomide) in Combination With a Corticosteroid Drug (Dexamethasone) for the Treatment of Multiple Myeloma

Who this might be right for
Plasma Cell MyelomaRecurrent Plasma Cell MyelomaRefractory Plasma Cell Myeloma+1 more
Mayo Clinic 17
Not applicableStudy completedNCT03477760
What this trial is testing

Multi-Drug Resistant Bacteria Carriage After Travel

Who this might be right for
Beta Lactam Resistant Bacterial Infection (Disorder)
Hopital Lariboisière 300
Not applicableStudy completedNCT05293418
What this trial is testing

Incidence of Colonization by Multidrug-resistant Organisms in Mechanically Ventilated Patients With Severe COVID-19

Who this might be right for
COVID-19Bacterial InfectionsColonization, Asymptomatic
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico 435
Large-scale testing (Phase 3)Study completedNCT02342886
What this trial is testing

Shortening Treatment by Advancing Novel Drugs

Who this might be right for
Tuberculosis, Pulmonary, Drug SensitiveTuberculosis, Pulmonary, Multi Drug-resistant
Global Alliance for TB Drug Development 284
Not applicableLooking for participantsNCT05633056
What this trial is testing

An Adaptive Randomized Controlled Trial

Who this might be right for
Multi Drug Resistant TuberculosisHIV Infections
Columbia University 360
Large-scale testing (Phase 3)Study completedNCT03086486
What this trial is testing

Various Doses and Durations of Linezolid Plus Bedaquiline & Pretomanid in Participants With Drug Resistant Tuberculosis

Who this might be right for
Tuberculosis, PulmonaryTuberculosis, Multidrug-ResistantTuberculosis, MDR+4 more
Global Alliance for TB Drug Development 181
Not applicableStudy completedNCT03248999
What this trial is testing

Prevalence of ESBL-producing Enterobacteriaceae as Carbapenem-resistant Enterobacteriaceae in Nursing Homes.

Who this might be right for
Drug Resistance, Bacterial
Centre Hospitalier Universitaire de Besancon 264
Testing effectiveness (Phase 2)UnknownNCT05831969
What this trial is testing

Lenalidomide to Reverse Drug Resistance After First-line Treatment of Advanced HCC

Who this might be right for
Advanced HCC
Shenyang Tenth People's Hospital 23
Large-scale testing (Phase 3)WithdrawnNCT02134106
What this trial is testing

Randomized-controlled Trial (RCT) on Combination Antibiotic for Infections Caused by Gram-negative Bacteria

Who this might be right for
BacteremiaHealthcare-associated PneumoniaVentilator-associated Pneumonia
Tan Tock Seng Hospital
Testing effectiveness (Phase 2)Study completedNCT00069160
What this trial is testing

Tariquidar and Docetaxel to Treat Patients With Lung, Ovarian, Renal and Cervical Cancer

Who this might be right for
Lung NeoplasmsOvarian NeoplasmsCervix Neoplasms+1 more
National Cancer Institute (NCI) 48
Very early researchNot Yet RecruitingNCT07674147
What this trial is testing

RD06-05 Universal CD19/BCMA CAR-T for Refractory Pediatric Autoimmune Diseases

Who this might be right for
Autoimmune DiseasesSLE - Systemic Lupus ErythematosusSSc-Systemic Sclerosis+3 more
The Children's Hospital of Zhejiang University School of Medicine 30
Large-scale testing (Phase 3)UnknownNCT04406727
What this trial is testing

UB-421 in Combination With Optimized Background Regimen in Patients With Multi-drug Resistant HIV-1 Infection

Who this might be right for
HIV-1 Infection
United BioPharma 50
Next Page